Pulmonary function and high-resolution CT findings five years after disease onset in patients with Wegener's granulomatosis

Scandinavian Journal of Rheumatology

Volumn 34, Issue 3, 2005, Pages 220-228

  Koldingsnes, Wenche ^a   Jacobsen, E A ^b   Sildnes, T ^a   Hjalmarsen, A ^a   Nossent, H C ^c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; FEMALE; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DIFFUSION; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG NODULE; MALE; PLEURA THICKENING; PRIORITY JOURNAL; RISK FACTOR; TOTAL LUNG CAPACITY; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; REGISTRIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; WEGENER GRANULOMATOSIS;

EID: 22144474074     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410011271     Document Type: Article

References (45)

1. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116: 488-98.
2. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021-32.
3. Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997;40:2187-98.
4. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology 2002; 41:572-81.
5. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest 1990;97:906-12.
6. Specks U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001;13:12-17.
7. Jayne D. Evidence-based treatment of systemic vasculitis. Rheumatology 2000;39:585-95.
8. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
9. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991;15:315-33.
10. Kuhlman JE, Hruban RH, Fishman EK. Wegener granulomatosis: CT features of parenchymal lung disease. J Comput Assist Tomogr 1991;15:948-52.
11. Weir IH, Muller NL, Chiles C, Godwin JD, Lee SH, Kullnig P. Wegener's granulomatosis: findings from computed tomography of the chest in 10 patients. Can Assoc Radiol J 1992;43:31-4.
12. Papiris SA, Manoussakis MN, Drosos AA, Kontogiannis D, Constantopoulos SH, Moutsopoulos HM. Imaging of thoracic Wegener's granulomatosis: the computed tomographic appearance. Am J Med 1992;93:529-36.
13. Reuter M, Schnabel A, Wesner F, Tetzlaff K, Risheng Y, Gross WL, et al. Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. Chest 1998;114:500-6.
14. Grotz W, Mundinger A, Wurtemberger G, Peter HH, Schollmeyer P. Radiographic course of pulmonary manifestations in Wegener's granulomatosis under immunosuppressive therapy. Chest 1994;105:509-13.
15. Attali P, Begum R, Ban Romdhane H, Valeyre D, Guillevin L, Brauner MW. Pulmonary Wegener's granulomatosis: changes at follow-up CT. Eur Radiol 1998;8:1009-113.
16. Rosenberg DM, Weinberger SE, Fulmer JD, Flye MW, Fauci AS, Crystal RG. Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 1980;69:387-94.
17. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000;43:2481-7.
18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. 1990;33:1101-7.
19. Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Bailliere's Clin Rheumatol 1997;11:423-46.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report of the Working Party on Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;16:5-40.
21. Becklake M, Crapo RO, Buist AS, Burrows B, Clausen JL, Coates AL, et al. Lung function testing; selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
22. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ. Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972;42:325-35.
23. Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200: 327-31.
24. Kallenberg CG, Cohen Tervaert JW. In: Ball GV, Bridges L Jr, editors. Vasculitis, 1st edn. Oxford: Oxford University Press, 2002:139-49.
25. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998 12;339:1448-56.
26. Klahr S. Progression of chronic renal disease. Heart Dis 2001;3:205-9.
27. Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996;154:1851-6.
28. Andonopoulos AP, Constantopoulos SH, Drosos AA, Moutsopoulos HM. Pulmonary function of nonsmoking patients with rheumatoid arthritis in the presence and absence of secondary Sjogren's syndrome, a controlled study. Respiration 1988;53:251-8.
29. Salorinne Y. Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases. Scand J Respir Dis, 1-84.
30. Nakano M, Hasegawa H, Takada T, Ito S, Muamatsu Y, Satoh M, et al. Pulmonary diffusion capacity in patients with systemic lupus erythematosus. Respirology 2002;7: 45-9.
31. Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol 2003;30:80-8.
32. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48:516-22.
33. Tylen U, Boijsen M, Ekberg-Jansson A, Bake B, Lofdahl CG. Emphysematous lesions and lung function in healthy smokers 60 years of age. Respir Med 2000;94:38-43.
34. Morrison NJ, Abboud RT, Ramadan F, Miller RR, Gibson NN, Evans KG, et al. Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989;139:1179-87.
35. McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-22.
36. Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. Am J Roentgenol 1996;166:301-7.
37. Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001;16:282-9.
38. Pretorius ES, Stone JH, Hellmann DB, Fishman EK. Wegener's granulomatosis: spectrum of CT findings in diagnosis, disease progression, and response to therapy. Crit Rev Diagn Imaging 2000;41:279-313.
39. Maskell GF, Lockwood CM, Flower CD. Computed tomography of the lung in Wegener's granulomatosis. Clin Radiol 1993;48:377-80.
40. Kiris A, Ozgocmen S, Kocakoc E, Ardicoglu O, Ogur E. Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol 2003;47:71-6.
41. Seo JB, Im JG, Chung JW, Song JW, Goo JM, Park JH, et al. Pulmonary vasculitis: the spectrum of radiological findings. Br J Radiol 2000;73:1224-31.
42. Zisman DA, McCune WJ, Tino G, Lynch JP 3rd. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vase Diffuse Lung Dis 2001;18:243-52.
43. Dawson JK, Graham DR, Desmond J, Fewins HE, Lynch MP. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology 2002;41: 262-7.
44. Bedrossian CW, Sussman J, Conklin RH, Kahan B. Azathioprine-associated interstitial pneumonitis. Am J Clin Pathol 1984;82:148-54.
45. Mouly S, Brillet G, Stern M, Lesavre P, Guillevin L. Pulmonary giant bulla in Wegener's granulomatosis. Scand J Rheumatol 2002;29:333-5.